Children's Cancer Institute recognised in Cancer Institute NSW's Translational Program Grants
March 5, 2015
Children's Cancer Institute's outstanding research work has been recognised by the Cancer Institute NSW's Translational Program Grants, announced yesterday by NSW Minister for Health and Medical Research, The Hon Jillian Skinner MP.
Professors Glenn Marshall, Michelle Haber AM and Murray Norris at Children’s Cancer Institute, together with Dr Claire Wakefield at the Kids Cancer Centre, were awarded $3.75 million to continue their translational work, that allows laboratory findings to move from the bench top to the patient’s bedside.
“Childhood cancer remains the most common cause of death from disease in Australian children,” says Prof Marshall.
“This funding provides hope for children with relapsed cancer as we trial new treatments focusing on neuroblastoma, the third most common type of childhood cancer after leukaemia and brain tumours.
“This funding will also allow us to continue our clinical research into new anticancer therapies that target the MYC gene, commonly activated in both adult and child cancers, for use in several early phase clinical trials.”
Awarded to four teams of NSW researchers, Cancer Institute NSW‘s Translational Program Grants will support the investigation of individualised treatments for ovarian cancer, new therapeutic approaches to childhood cancers, better management of cancer-related anxiety and depression and the prevention and treatment of chemotherapy-induced nerve damage.
See Cancer Institute NSW’s announcement of the grants on their website.
Children’s Cancer Institute relies on grants and community support to complete our work. Every dollar we receive from government and granting bodies to support direct research costs must be matched with a dollar raised by the community through partnerships, donations and fundraising to cover the indirect costs of our work. We are constantly under pressure to raise more funds as our research portfolio expands. Without dedicated funding and the help of our supporters – which include community fundraisers, corporate partners, individual donors, supporters and volunteers – we’re unable to complete the vital research we know will uncover a cure for childhood cancer.
About Children’s Cancer Institute
Originally founded by two fathers of children with cancer in 1976, Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to research into the causes, prevention and cure of childhood cancer. Forty years on, our vision remains unchanged – to save the lives of all children with cancer and to eliminate their suffering. The Institute has grown to now employ more than 220 researchers, operational staff and students, and has established a national and international reputation for scientific excellence.
Our focus is on translational research, and we have an integrated team of laboratory researchers and clinician scientists who work together in partnership to discover new treatments which can be progressed from the lab bench to the beds of children on wards in our hospitals as quickly as possible. These new treatments are specifically targeting childhood cancers, so we can develop safer and more effective drugs and drug combinations that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.
We are currently leading the establishment of the Zero Childhood Cancer national child cancer personalised medicine program for children with the most aggressive cancers, in partnership with the Sydney Children’s Hospitals Network. This program will revolutionise the way treatment decisions are made, with the aim of improving survivorship for those children at highest risk of treatment failure from their disease.